{"nctId":"NCT05386069","briefTitle":"Does a Non-Opioid Multimodal Pain (NOMO) Protocol Decrease Narcotic Use","startDateStruct":{"date":"2019-11-15","type":"ACTUAL"},"conditions":["Opioid Use"],"count":10,"armGroups":[{"label":"Control Arm","type":"NO_INTERVENTION","interventionNames":[]},{"label":"Treatment Arm","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: NOMO Protocol"]}],"interventions":[{"name":"NOMO Protocol","otherNames":["Standard Care"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* English-speaking females\n* greater than or equal to 18 years old\n* scheduled for a urogynecologic procedure at GHS requiring inpatient stay or extended observation.\n\nExclusion Criteria:\n\n* less than 18 years of age\n* non-English speaking patients\n* unscheduled urogynecologic surgeries\n* patients expected to undergo a simple reconstructive surgery with same-day discharge,\n* history of chronic pain\n* chronic Lyrica or Celebrex use\n* psychiatric disorder, narcotic dependence or narcotic prescription in the past six weeks\n* current liver disease\n* kidney disease (defined as GFR \\<60)\n* malignancy\n* sulfa allergy","healthyVolunteers":true,"sex":"FEMALE","genderBased":true,"genderDescription":"Females undergoing Urogynecology procedure","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Morphine Milligram Equivalents Used During Inpatient Stay","description":"Total morphine milligram equivalents calculated for each patient during their stay.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10.8","spread":"5.6"},{"groupId":"OG001","value":"8.8","spread":"7.1"}]}]}]},{"type":"SECONDARY","title":"Passage of Voiding Trial","description":"percentage of patients who pass voiding trial on POD#1","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]}]},{"type":"SECONDARY","title":"Anti-emetic Use","description":"Did the patient require anti-emetics in the post-operative period","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"5","spread":null}]}]}]},{"type":"SECONDARY","title":"Patient Pain Score","description":"Evaluated via the \"Brief Pain Inventory (Short Form)\"; rate pain on scale 0-10, 10 being worst","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.8","spread":null},{"groupId":"OG001","value":"2.4","spread":null}]}]}]},{"type":"SECONDARY","title":"Prescription for Opioid at Discharge","description":"Did the patient require a narcotic prescription","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Length of Hospital Stay","description":"The average number of days patients were admitted as inpatient.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":5},"commonTop":[]}}}